Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» chronic rhinosinusitis with nasal polyps
chronic rhinosinusitis with nasal polyps
How AZ and Amgen’s Tezspire respiratory data ups the ‘level of ambition’ in immunology
Pharma Voice
Thu, 03/27/25 - 11:06 am
Amgen
AstraZeneca
nasal polyps
Tezspire
chronic rhinosinusitis with nasal polyps
Amgen and AstraZeneca report results from Phase III trial of Tezspire for CRSwNP
Clinical Trials Arena
Mon, 03/3/25 - 10:19 am
Amgen
AstraZeneca
clinical trials
Tezspire
chronic rhinosinusitis with nasal polyps
GSK gears up for depemokimab debut with twin FDA filings and phase 3 data dump
Fierce Biotech
Mon, 03/3/25 - 10:18 am
GSK
depemokimab
FDA
chronic rhinosinusitis with nasal polyps
asthma
AstraZeneca and Amgen’s Tezspire succeeds in Phase III nasal polyps trial
Clinical Trials Arena
Fri, 11/8/24 - 11:34 am
AstraZeneca
Amgen
clinical trials
Tezspire
chronic rhinosinusitis with nasal polyps
GSK asthma hope depemokimab works in second indication
Pharmaphorum
Mon, 10/14/24 - 10:01 am
GSK
depemokimab
clinical trials
chronic rhinosinusitis with nasal polyps
Weak data for Fasenra undermine AZ’s ambitions for the drug
Pharmaphorum
Tue, 10/25/22 - 10:35 am
AstraZeneca
Fasenra
eosinophilic asthma
chronic rhinosinusitis with nasal polyps
eosinophilic esophagitis
